Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 4
4 · NATURES SUNSHINE PRODUCTS INC · Filed Jun 27, 2025
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2025-06-27$11.46/sh−2,854,607$32,713,796→ 0 total(indirect: by Fosun Pharma USA Inc.)
Holdings
- 64,167(indirect: by Fosun Industrial Co., Limited)
Common Stock
Footnotes (3)
- [F1]The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto.
- [F2]Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- [F3]Fosun Industrial Co., Limited is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.